Conference Coverage
The Latest

CROI 2021 Highlights: New HIV Research With Clinical Impact
Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists
A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?
Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV
David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

Anal Cancer Screening Must Include Women Living With HIV, Researchers Say
The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.

CROI 2021 Data Bites: HIV Treatment and the Care Continuum
Our bite-sized study summaries include new research on antiretrovirals in development, trends in antiretroviral initiation speed and viral suppression rates in the U.S., and the link between gender-affirming surgery and an undetectable viral load.

CROI 2021 Data Bites: HIV and COVID-19
There's new research on the risk of severe COVID-19 among people living with HIV, as well as prevention and treatment options.

Major Conference on HIV and COVID-19 Under Fire for Putting Science Behind Paywall
For the first time, the influential annual CROI was going to postpone making its ample data available to the public. But the global HIV community swiftly protested.

CROI 2021 Data Bites: HIV-Related Complications and Comorbidities
Newly reported research includes deep dives into many health issues commonly experienced by people living with HIV, including cancer, cardiovascular disease, depression/anxiety, and metabolic disorders.

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021
Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.